Skin News and Research

RSS

Smokers with systemic lupus erythematosus at greater risk of skin damage and rashes

As if there weren't enough reasons to stop smoking, a team of researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) have just found another. A study led by Dr. Christian A Pineau, Co-Director of the Lupus and Vasculitis clinic at the MUHC, has clearly linked skin damage and rashes to smoking in people with systemic lupus erythematosus (SLE). The study was published in a recent issue of the Journal of Rheumatology.

3 Nov 2009

Early tolerance of proton therapy excellent in prostate cancer patients

Proton beam therapy can be safely delivered to men with prostate cancer and has minimal urinary and rectal side effects, according to a study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago.

3 Nov 2009

Interim data from Schering-Plough's narlaprevir Phase IIa study

Schering-Plough Corporation reported that interim results from an ongoing Phase IIa study of narlaprevir (SCH 900518), its investigational, once-daily protease inhibitor, demonstrated potent antiviral activity in treatment-naive patients with chronic hepatitis C virus (HCV) genotype 1.

3 Nov 2009

IMC-RT does not benefit breast cancer patients

After mastectomy, breast cancer patients who receive radiation treatment to the lymph nodes located behind the breast bone do not live longer than those who do not receive radiation to this hard-to-treat area, according to a randomized 10-year study presented at the plenary session, November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

3 Nov 2009

Extra dose of proton radiation therapy reduces prostate cancer recurrences

Men who receive a "boost" of proton therapy after receiving a standard course of X-ray radiation therapy have fewer recurrences of their prostate cancer compared to men who did not receive the extra dose of proton radiation, according to a first-of-its-kind study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago.

3 Nov 2009

New imaging technique for treatment of breast cancer

Researchers at Rush University Medical Center and Argonne National Laboratory are collaborating on a study to determine if an imaging technique used by NASA to inspect the space shuttle can be used to predict tissue damage often experienced by breast cancer patients undergoing radiation therapy. The study is examining the utility of three-dimensional thermal tomography in radiation oncology.

3 Nov 2009

Switching to new immunosuppressant drug may reduce skin cancer after kidney transplantation

Switching to a newer type of immunosuppressant drug may reduce the high rate of skin cancer after kidney transplantation, according to research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.

2 Nov 2009

MRSA bloodstream infection linked to high mortality rate

A strain of MRSA that causes bloodstream infections is five times more lethal than other strains and has shown to have some resistance to the potent antibiotic drug vancomycin used to treat MRSA, according to a Henry Ford Hospital study.

2 Nov 2009

Bioengineers develop nano-delivery system for cancer therapy

Going smaller could bring better results, especially when it comes to cancer-fighting drugs.

2 Nov 2009

Nu Skin Enterprises celebrates 25th Anniversary Convention in LA

Nu Skin Enterprises, Inc. (NYSE: NUS) concluded its 25th Anniversary Convention in Los Angeles with record attendance, record product sales and record contributions to its nonprofit foundation. The biannual global distributor convention attracted more than 12,000 distributors from the company's 48 international markets. The largest delegations of sales representatives came from the United States, Japan and Korea.

31 Oct 2009

Shire announces Phase IIIb study results of Daytrana

Shire plc, the global specialty biopharmaceutical company, today announced findings at a major medical meeting from a Phase IIIb study of the tolerability and effectiveness of Daytrana® (methylphenidate transdermal system) in adolescents aged 13 to 17 years diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).

31 Oct 2009

Patients who acquire SSTIs in healthcare settings may stay longer in hospitals to control the infection

Patients who acquire skin and soft tissue infections (SSTIs) in a hospital or other healthcare setting may be more likely to receive inappropriate antibiotic therapy at the beginning of their treatment. As a result, they also may have significantly longer hospital stays to control the infection.

31 Oct 2009

Innovative optical system to study the complex mechanisms that lead to sudden cardiac arrest developed

A research team at Vanderbilt University has developed an innovative optical system to simultaneously image electrical activity and metabolic properties in the same region of a heart, to study the complex mechanisms that lead to sudden cardiac arrest.

31 Oct 2009

Bacterial or viral skin infections continue to grow among high school and college athletes, survey reveals

A recent survey of nearly 650 athletic trainers across the U.S. revealed that in the past 12 months nearly 76 percent of the respondents' athletic programs, mostly high school- and college-based, bacterial or viral skin infections have developed.

30 Oct 2009

Health officials stress the need for continued prevention efforts in view of H1N1 vaccine delay

Responding to delays in the nationwide distribution H1N1 flu vaccine, Department of Health officials today urged Pennsylvanians to continue to take steps to prevent the spread of illness.

30 Oct 2009

Genetists identify gene signature expressed in skin associated with the occurrence of lung disease

At its most benign, the autoimmune disease scleroderma can discolor parts of the skin of its sufferers. At its most pernicious, it can thicken and harden their skin, their blood vessels, and their internal organs before, in many cases, killing them.

30 Oct 2009

Dr. Chao Herbal Drink Line releases two all-natural, vegan beverages

The Dr. Chao Herbal Drink Line released two all-natural, vegan beverages to enhance sexual health and combat premenstrual symptoms. The new Adult and Lady drinks have no sugar, artificial sweeteners or preservatives, glutens, and caffeine, do not require costly prescriptions and have health benefits derived from the recipes of a 19th-century Chinese herbalist.

30 Oct 2009

UCSF scientists receive grants to advance stem cell based strategies for diabetes and brain tumors

Two teams of UCSF scientists have received grants from the California Institute for Regenerative Medicine to advance their stem cell based strategies for treating diabetes and brain tumors.

30 Oct 2009

Diabetes may damage nerves in the skin leading to dry skin, say experts

As American Diabetes Month approaches, leading experts like Dr. Jacqueline Sutera, DPM, stress the importance of foot care, especially for those with diabetes. People with diabetes are at a greater risk of developing dry skin due to nerve damage.

30 Oct 2009

Aerobics and resistance training exercise prevent visceral fat gain

A study conducted by exercise physiologists in the University of Alabama at Birmingham (UAB) Department of Human Studies finds that as little as 80 minutes a week of aerobic or resistance training helps not only to prevent weight gain, but also to inhibit a regain of harmful visceral fat one year after weight loss.

30 Oct 2009

Skin News and Research

Smokers with systemic lupus erythematosus at greater risk of skin damage and rashes

Early tolerance of proton therapy excellent in prostate cancer patients

Interim data from Schering-Plough's narlaprevir Phase IIa study

IMC-RT does not benefit breast cancer patients

Extra dose of proton radiation therapy reduces prostate cancer recurrences

New imaging technique for treatment of breast cancer

Switching to new immunosuppressant drug may reduce skin cancer after kidney transplantation

MRSA bloodstream infection linked to high mortality rate

Bioengineers develop nano-delivery system for cancer therapy

Nu Skin Enterprises celebrates 25th Anniversary Convention in LA

Shire announces Phase IIIb study results of Daytrana

Patients who acquire SSTIs in healthcare settings may stay longer in hospitals to control the infection

Innovative optical system to study the complex mechanisms that lead to sudden cardiac arrest developed

Bacterial or viral skin infections continue to grow among high school and college athletes, survey reveals

Health officials stress the need for continued prevention efforts in view of H1N1 vaccine delay

Genetists identify gene signature expressed in skin associated with the occurrence of lung disease

Dr. Chao Herbal Drink Line releases two all-natural, vegan beverages

UCSF scientists receive grants to advance stem cell based strategies for diabetes and brain tumors

Diabetes may damage nerves in the skin leading to dry skin, say experts

Aerobics and resistance training exercise prevent visceral fat gain

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News